Search hospitals > Nevada > Reno
Saint Mary's Regional Medical Center
Claim this profileReno, Nevada 89503
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
170 reported clinical trials
3 medical researchers
Summary
Saint Mary's Regional Medical Center is a medical facility located in Reno, Nevada. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Saint Mary's Regional Medical Center is involved with conducting 170 clinical trials across 343 conditions. There are 3 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, and Samuel Chacon, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
John A. EllertonOptumCare Cancer Care at Fort Apache6 years of reported clinical research
Expert in Breast Cancer
Expert in Lung Cancer
158 reported clinical trials
235 drugs studied
Alan K. IkedaAlliance for Childhood Diseases/Cure 4 the Kids Foundation8 years of reported clinical research
Expert in Cancer
Studies Neuroblastoma
55 reported clinical trials
111 drugs studied
Samuel Chacon, MDSaint Mary's Regional Medical Center4 years of reported clinical research
Studies Urinary Tract Infection
Studies Stress Incontinence
1 reported clinical trial
2 drugs studied
Clinical Trials running at Saint Mary's Regional Medical Center
Bladder Cancer
Lung Cancer
Esophageal cancer
Breast Cancer
Kidney Cancer
Bladder Carcinoma
Breast cancer
Gastric cancer
Testicular cancer
Cancer
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
Blood Sample Collection
for Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting1 award N/A9 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Mary's Regional Medical Center?
Saint Mary's Regional Medical Center is a medical facility located in Reno, Nevada. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Saint Mary's Regional Medical Center is involved with conducting 170 clinical trials across 343 conditions. There are 3 research doctors associated with this hospital, such as John A. Ellerton, Alan K. Ikeda, and Samuel Chacon, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.